Misra et al. reported that enhanced integrin β3 signaling is a crucial link between elastin deficiency and arterial hypermuscularization and that integrin β3 blockade is a promising and much needed noninvasive therapeutic approach for supravalvular aortic stenosis 17. The gene discussed is ELN; the disease is supravalvular aortic stenosis.